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Abstract
Oxidative stress, a reaction caused by the imbalance between the reactive oxygen species
of human organism and its ability to detoxify reactive intermediates and to repair the re-
sulting damage plays an important role in HIV-infections. On one hand, HIV infection is
responsible for the chronic oxidative stress of the patients. On the other hand, the oxidative
stress contributions to the HIV disease pathogenesis. In this paper, we integrate oxidative
stress into an HIV infection model to investigate its effects on the virus dynamics. Through
mathematical analysis, we obtain the basic reproduction number R0 of the model which de-
scribes the persistence of viruses. In particular, we show that for R0 > 1, the model has a
bistable interval with virus rebound threshold and elite control threshold. Numerical simu-
lations and bifurcation analysis are presented to illustrate the viral dynamics under oxidative
stress. Our investigation reveals the interplay between viruses and the reaction of human
organism including immune response and oxidative stress, and their effects on the health of
human being.
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1. Introduction
Combination antiretroviral therapy gives patients long-term suppression of HIV with un-
detectable viral levels. Recent investigations show that for patients with undetectable viral
levels, there exists a reservoir in which viruses remain alive in a long-lived latent state. With
the termination of receiving combination antiretroviral therapy, after an average time period
of 18 days, plasma viremia rebounds to detectable level. In the literature, medical cases of
HIV rebound were reported. Medical examinations for the ‘Mississippi baby’ at the age of
nearly 4 years old displayed a rebounded HIV level in blood (16,750 copies/ml) [1]. The
‘Mississippi baby’ case implies that there exists a time delay for the viral rebound [1, 2].
Researches had been carried to explain such phenomena [2, 3].
Conwayand Perelson [3] developed a mathematical system to model to study the dynam-
ics of HIV infection. Their investigation captures the interplay between viral dynamics and
the response of the host and brings insight into the evolution of the disease infection pro-
cess. By evaluating the designed model, the authors predicted that the strength of immune
response and the initial size of the latent reservoir could affect the dynamics. Their results
on post-treatment control provide guidance for future studies. Investigations implies that
after HIV infection, patients who receive antiretroviral therapy early have a higher chance
of getting post-treatment control, a situation where the amount of plasma virus remains un-
detectable after the termination of the medical treatment. However, clinically, only a small
proportion of such patients that receive early treatment attain post-treatment control. Fur-
ther investigations are to be carried out to reveal the mechanism behind the post-treatment
control.
As a highly reactive oxygen species (ROS), oxidants are continuously produced during
normal biochemical reactions in the human body. Most cells are able to detoxify physio-
logic levels of ROS in the human body using antioxidants such as enzymes. The processes
of producing oxidants and detoxication may reach an equilibrium state. When the balance
between the two processes disturbed, a condidtion called oxidative stress occurs [4]. Antiox-
idants play an important role in regulating the reactions that release free radicals. Cells need
to reach certain level of antioxidant defenses to counteract the detrimental effects caused by
an excessive production of ROS to protect the immune system [5]. Investigations suggest the
existence of interactions between HIV-infection and oxidative stress. On one hand, the HIV-
infection process contributes to the disturbance of the balance between the generation of free
radicals and antioxidant defenses. On the other hand, oxidative stress is beneficial to HIV
disease pathogenesis by promoting the replication of viruses, decreasing the proliferation of
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immune cells, and increasing the sensitivity to drug toxicities etc [6].
After HIV infection, the initial reaction of the host is rapid and nonspecific by activating
natural killer cells, macrophage cells, etc. The host develops delayed and specific reactions
by activating CTLs and antibody cells. During most viral infections, CTLs attack infected
cells and antibody cells attack viruses. These attacks against the viruses act as an antiviral
defense for the host. Dynamics of viral infection with CTL response have been investigated
in the literature. [7] introduced a mathematical system to model the interplay between acti-
vated CD4+ T cells, infected CD4+ T cells, viruses and immune cells. [8] and [9] performed
investigation on the HIV infection and concluded that the turnover of free virus is much
faster than that of infected cells. Based on these results, they proposed the quasi-steady state
assumption, i.e., the load of free virus is proportional to the amount of infected cells. Thus
we can estimate the viral load by evaluating the number of infected cells.
Investigations demonstrated that HIV mutates into new forms that escape from specific
immune responses or immune exhaustion during virus evolution [10–17]. HIV infection
may modulate dendritic cells, which are responsible for the viral evasion from immunity
[18]. During the first stage of HIV infection, the viruses moderately decrease the amount
of CD4+ T cells within the host. Then, the level of CD4+ T cell remains almost constant
for several years due to the inhibition provided by the immune response. [19] modeled
the interrelationship among timing, efficiency and success of antiviral drug therapy. [18]
performed investigations on a variety of HIV models with immune impairment. The authors
show that when the impairment rate of HIV overwhelms the threshold value, immune system
of the host may collapse. [20, 21] constructed mathematical models to study the infection
of HIV and carried out analysis to obtain a ‘risky threshold’ and an ‘immunodeficiency
threshold’ for the impairment rate. Their investigations implies that when the impairment
rate is greater than a threshold value, the immune system of the host always collapses.
During the early stage of an HIV infection, latent HIV reservoirs will be formed in the
host. Latent reservoirs survive the antiretroviral therapy (ART) and remain alive even when
the level of HIV in the blood is undetectable. Thus, the existence of such reservoir is a barrier
to the elimination of HIV. HIV infection dynamics with latent reservoirs have been investi-
gated in the literature[22–25]. [25] investigated the HIV infection with latent reservoirs by
constructing a stochastic model. The authors showed that the latent reservoir has relatively
stable size and cells can be activated to produce virions. [22] investigated influence of on-
going viral replication on the evolution of latent reservoirs and revealed the influences of a
variety of viral and host factors on the dynamics of the latent reservoirs. [24] established a
3
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mathematical model to investigate the activation of latently infected cells and revealed the
mechanism behind the replenishment of the latent reservoirs.
In this article, we integrate oxidative stress into HIV infection model to consider the
interplay between viruses and corresponding oxidative stress, and their combined effects on
the host. The within host model is given by

dx(t)
dt
= s − dx(t) − (1 − ǫ)βx(t)y(t),
dL(t)
dt
= αL(1 − ǫ)βx(t)y(t) + (ρ − a − dL)L(t),
dy(t)
dt
= (1 − αL)(1 − ǫ)βx(t)y(t) + aL(t) − δy(t) − py(t)z(t),
dz(t)
dt
=
cy(t)z(t)
1 + ηy(t)
K(y) − bz(t),
(1.1)
where x denotes activated CD4+ T cells, L viral latent reservoir, y infected CD4+ T cells and z
immune cells. Since HIV dynamics are known to be more rapid than infected cell dynamics,
we make the quasi-steady assumption. Thus, the HIV cells are in proportion to the infected
cells. Here we use the overall treatment effectiveness, denoted by ǫ, for 0 ≤ ǫ ≤ 1, to
describe their combined treatment effectiveness. In particular, when ǫ = 1, the therapy is
100% effective. On the other hand, if the treatment is terminated, ǫ = 0 [3, 23].
The relationship between the ROS and antioxidant can be evaluated using the method
proposed in [26]. [27–29] investigated the role of ROS in HIV infection. In this article,
we are particularly interested in the effects of the oxidative stress on the process of viral
infection. Since oxidative stress slows down the activation of the immune system, we hereby
introduce the expression K(y) = 1+h
β(y)
to model the influence of the oxidative stress. Since
reactive oxygen species (ROS) are responsible for the oxidative stress, here use ρ(y) = k0 +
yk1
y+y0
to model oxidative stress in the HIV infection model. Here, k0, k1 and y0 are constants.
We notice that ρ(y) is a saturating, increasing function of y. In order to simplify the analysis,
we linearize the expression of ρ(y) to obtain ρ(y) = k0 +
k1 y
y0
. Letting k0 = k and
k1 y
y0
= r, we
obtain ρ(y) = k + ry. It thus follows that
K(y) =
1 + h
k + ry
.
ROS damage, the immune term is modeled using the expression
cyz
1+ηy
K(y)−bz. We notice
that such immune term is different from the widely used immune and immune impairment
function
cyz
1+ηy
− bz − myz [19, 30–32] (m is the rate of immune impairment). Here constant h
represents the influence of antioxidant on the immune response, k is the influence of naturally
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produced oxidant, and r is the influence of oxidant produced by infected CD4+ T cells or HIV
viral load y.
The rest of this article is organized as follows. In, Section 2, we present some prelimi-
nary results on the structure of the equilibria of the model. We then, in Section 3, perform
stability analysis on the equilibria. In Section 4, based on our stability analysis, we present
sensitive analysis and numerical simulations. Finally, in Section 5, we conclude the paper
with discussions and a summary.
2. Preparation
2.1. Positiveness and boundedness
In the following, we show that system (1.1) is well-posed.
Theorem 2.1. System (1.1) has a unique and nonnegative solution with the initial con-
dition (x(0), L(0), y(0), z(0)) ∈ R4
+
, where R4
+
= {(x1, x2, x3, x4)|x j ≥ 0, j = 1, 2, 3, 4}. Further-
more, the solution is bounded.
Proof. By the fundamental theory of ordinary differential equations, system (1.1), with
nonnegative initial conditions, has a unique solution. For any nonnegative initial data, let
t1 > 0 be the first time that x(t1) = 0. The first equation of (1.1) implies that x˙(t1) = s > 0.
That is to say, x(t) < 0 for t ∈ (t1 − ε1, t1), where ε1 is an arbitrarily small positive constant.
The above discussion leads to a contradiction. It thus follows that x(t) is always posi-
tive. Because z = 0 is a constant solution of the last equation of (1.1), it follows from the
fundamental existence and uniqueness theorem that z > 0 for all t > 0.
Suppose that at time t2 > 0, y(t2)z(t2) reaches 0 for the first time. Thus, we have
(i) L(t2) = 0, y(t) ≥ 0 for t ∈ [0, t2], or
(ii) y(t2) = 0, L(t) ≥ 0 for t ∈ [0, t2].
For case(i), because x(t) is positive, it follows from the variation of constants formula
that L(t2) = L(0)+ e
−
∫ t2
0
(a+dL−ρ)dξ
∫ t2
0
αL(1− ǫ)βx(ξ)y(ξ)dξ > 0, which is in contradiction with
L(t2) = 0.
For case (ii), the third equation of system (1.1) implies that
y(t2) = y(0) + e
∫ t2
0
[(1−αL)(1−ǫ)βx(ξ)−δ−pz(ξ)]dξ
∫ t2
0
aL(ξ)dξ > 0, which contradicts y(t2) = 0.
Thus, L(t) and y(t) are always positive.
Next, we expatiate upon the boundedness of the solutions to (1.1). Let
M(t) = σx(t) + aL(t) + (a + dL − ρ)y(t) +
pk(a + dL − ρ)z(t)
c(1 + h)
,
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where σ = aαL + (1 − αL)(a + dL − ρ). Since all solutions of (1.1) are positive, we have
dM
dt
= σ
[
s − dx − (1 − ǫ)βxy
]
+ a
[
αL(1 − ǫ)βxy + (ρ − a − dL)L
]
+(a + dL − ρ)
[
(1 − αL)(1 − ǫ)βxy + aL − δy − pyz
]
+
pk(a+dL−ρ)
c(1+h)
(
cyz
1+ηy
1+h
k+ry
− bz
)
≤ σs − σdx − (a + dL − ρ)δy − bpk(a+dL−ρ)zc(1+h)
< σs − νM.
Here ν = min
{
d, δ, b
}
. Let ϕ be the solution of

dϕ
dt
= σs − νϕ,
ϕ0 = σx0 + aL0 + (a + dL − ρ)y0 +
pk(a + dL − ρ)z0
c(1 + h)
,
where x0, y0 and z0 are initial values of system (1.1) and ϕ0 = M0 > 0. We then evaluate
limt→+∞ sup ϕ(t) =
σs
ν
. It follows from the comparison theorem [33] that M(t) < ϕ(t). Thus,
x(t), L(t), y(t) and z(t) are bounded. 
2.2. Thresholds
In the following, we consider the threshold values of the model. Such threshold charac-
terises the viral dynamics of model (1.1).
Let
R0 = (1 − ǫ)β
[
(1 − αL) + aαLa+dL−ρ
]
. s
d
. 1
δ
=
sβ(1−ǫ)
[
aαL+(1−αL)(a+dL−ρ)
]
dδ(a+dL−ρ) .
Because (1−ǫ)β. s
d
. 1
δ
is the basic reproductive number of the model without viral latent reser-
voir, R0 gives the basic reproductive number of model (1.1), which describes the average
number of newly infected cells generated from an infected cell at the beginning of the infec-
tious process.
Let
R∗± =
sβ(1−ǫ)
[
(1−αL)+ aαLa+dL−ρ
]
δ
[
d+
bβ(1−ǫ)
B∓
√
B2−4b2krη
2k
]
=
2bηrsβ(1−ǫ)
[
aαL+(a+dL−ρ)(1−αL)
]
δ(a+dL−ρ)
{
2bηrd+β(1−ǫ)
[
B±
√
B2−4b2krη
]} ,
where
B = c + ch − br − bkη.
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Because
sβ(1−ǫ)
δ[d+
bβ(1−ǫ)
c
]
is the basic immune reproductive number of the model with the bilinear
immune incidence (cyz) and without viral latent reservoir, R∗± represent the two thresholds in
addition to the basic reproductive ratio.
We also define the following thresholds
h1 =
br + bηk
c
− 2b
√
ηrk
c
− 1
and
h∗ =
br + bηk
c
+
2bηry1
c
− 1.
The post-treatment immune control threshold is then obtained as
h2 =
br + bηk
c
+
2b
√
ηrk
c
− 1,
and the elite control threshold is given by
h∗∗ =
br + bηk
c
+
bkβ(1 − ǫ)
cd(R0 − 1)
+
bdηr(R0 − 1)
cβ(1 − ǫ) − 1.
Denote Rc = 1 +
β(1−ǫ)
√
ηrk
drη
, we have the following results.
Lemma 2.1. R0 > Rc ⇔ h∗ > h∗∗.
Lemma 2.2. (i) If 1 < R0 < Rc, then R
∗
+
< 1, h∗ < h2 and R∗− > 1⇔ h > h∗∗.
(ii) If R0 > Rc, then h
∗ > h2, R∗− > 1 ⇔ h > h2 and R∗+ > 1⇔ h2 < h < h∗. 
2.3. Equilibria
In the following, we consider the existing conditions of equilibria of system (1.1).
System (1.1) always admits an uninfected equilibrium E0 = (x0, 0, 0, 0), where x0 =
s
d
.
(i) If R0 > 1, system (1.1) also has an immune-free equilibrium E1 = (x1, L1, y1, 0),where
x1 =
δ(a+dL−ρ)
β(1−ǫ)
[
aαL+(1−αL)(a+dL−ρ)
] ,
L1 =
αLβ(1−ǫ)x1y1
a+dL−ρ ,
y1 =
d(R0−1)
β(1−ǫ) .
(ii) If R∗− > 1 and 0 < h < h1 or h > h2, equation
cyz
1+ηy
1+h
k+ry
− bz = 0 has two positive roots.
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If R∗− > 1 and h > h2, system (1.1) has an immune equilibrium E
∗
− = (x
∗
−, L
∗
−, y
∗
−, z
∗
−). If
R∗
+
> 1 and h > h2, system (1.1) also has an immune equilibrium E
∗
+
= (x∗
+
, L∗
+
, y∗
+
, z∗
+
). Here
x∗± =
s
d+β(1−ǫ)y∗± ,
L∗± =
αL(1−ǫ)βx∗±y∗±
a+dL−ρ ,
y∗± =
B∓
√
B2−4b2krη
2bηr
,
z∗± =
δ(R∗±−1)
p
.
From Lemmas 2.1 and 2.2, summing up the above analysis yields the existing results of
equilibria of system (1.1)
Theorem 2.2. (i) System (1.1) always admits an uninfected equilibrium E0.
(ii) If R0 > 1, system (1.1) also has an immune-free equilibrium E1.
(iii) If 1 < R0 < Rc and h > h
∗∗, system (1.1) has only one positive equilibrium E∗
+
.
If R0 > Rc and h2 < h < h
∗, system (1.1) has two positive equilibria E∗− and E
∗
+
.
When R0 > Rc and h > h
∗, system (1.1) has only one positive equilibrium E∗
+
.
(iv) If R0 > Rc and h = h2, system (1.1) has only one positive equilibrium E∗. 
The existence results for positive equilibria are summarized in Tables 2.1 and 2.2.
h2 < h < h
∗∗ h > h∗∗
E∗
+
— exist
E∗− — —
Table 2.1: The existence of the positive equilibria when 1 < R0 < Rc.
h2 < h < h
∗ h > h∗
E∗
+
exist exist
E∗− exist —
Table 2.2: The existence of the positive equilibria when R0 > Rc.
3. Stability analysis
In this section, we consider the stabilities of equilibria for system (1.1).
8
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Let E˜ be any arbitrary equilibrium of system (1.1). Denote
J =

−d − β(1 − ǫ)y˜ 0 −β(1 − ǫ)x˜ 0
αLβ(1 − ǫ)y˜ ρ − a − dL αL(1 − ǫ)βx˜ 0
(1 − αL)β(1 − ǫ)y˜ a (1 − αL)β(1 − ǫ)x˜ − δ − pz˜ −py˜
0 0
c(1+h)z˜(k−ηry˜2)
(1+ηy˜)2(k+ry˜)2
c(1+h)y˜
(1+ηy˜)(k+ry˜)
− b

.
The characteristic equation of the linearized system of (1.1) at E˜ is then obtained as
∣∣∣λI −J ∣∣∣ = 0. (3.1)
3.1. Stability analysis of Equilibrium E0
Theorem 3.1. If R0 < 1, then the uninfected equilibrium E0 of system (1.1) is locally
asymptotically stable. If R0 > 1, E0 is unstable.
Proof. The characteristic equation (3.1) with respect to equilibrium E0(x0, 0, 0, 0) is∣∣∣∣∣∣∣∣∣∣∣∣∣∣
−d − λ 0 −β(1 − ǫ)x0 0
0 ρ − a − dL − λ αL(1 − ǫ)βx0 0
0 a (1 − αL)(1 − ǫ)βx0 − δ − λ 0
0 0 0 −b − λ
∣∣∣∣∣∣∣∣∣∣∣∣∣∣
= 0. (3.2)
It is clear that equation (3.2) has two negative roots −d and −b. The other two eigenvalues
are solutions of
λ2 + a1λ + a2 = 0, (3.3)
where
a1 = a + dL − ρ + δ[1 −
(1 − αL)(1 − ǫ)βx0
δ
],
a2 = (a + dL − ρ) − aβ(1 − ǫ)[δ − (1 − αL)(1 − ǫ)βx0] −
asβαL(1 − ǫ)
d
= δ(a + dL − ρ)(1 − R0).
It is easy to see that a1 > 0 and a2 > 0 for R0 < 1. When R0 < 1, equation (3.3) has
two negative roots indicating that E0 is locally stable. On the other hand, when R0 > 1, then
a2 < 0, and E0 is a saddle with dim W
s(E0) = 2 and dimW
u(E0) = 1, and hence unstable.
This completes the proof of Theorem 3.1. 
Theorem 3.2. If R0 < 1, then the uninfected equilibrium E0 of system (1.1) is global
asymptotically stable.
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Proof. Define a function
V =
1
2
(x − x0)2 + AL + By +
pB
c(1 + h)
z,
where A and B are positive coefficients to be undetermined. It is easy to see that V is a
positive Lyapunov function. Evaluating the time derivative of V along the solution of system
(1.1) yields
V˙ |(1.1) = (x − x0)
[
s − dx − (1 − ǫ)βxy
]
+ A
[
αL(1 − ǫ)βxy − (a + dL − ρ)L
]
+B
[
(1 − αL)(1 − ǫ)βxy + aL − δy − pyz
]
+
pB
c(1 + h)
(
cyz
1 + ηy
1 + h
k + ry
− bz
)
= (x − x0)
[
dx0 − dx − (1 − ǫ)βxy + (1 − ǫ)βx0y − (1 − ǫ)βx0y
]
+AαL(1 − ǫ)βxy − A(a + dL − ρ)L + B(1 − αL)(1 − ǫ)βxy
+BaL − Bδy − Bpyz + pB
c(1 + h)
cyz
1 + ηy
1 + h
k + ry
− pB
c(1 + h)
bz
≤ −
(
d + (1 − ǫ)βy
)
(x − x0)2 −
[
x0 − AαL − B(1 − αL)
]
(1 − ǫ)βxy
−
[
Bδ − (1 − ǫ)βx20
]
y −
[
A(a + dL − ρ) − Ba
]
L − pB
c(1 + h)
bz.
Choosing
A =
x0
(1 − αL)[a+dL−ρa + αL1−αL ]
,
B =
A(a + dL − ρ)
a
,
we get
x0 − AαL − B(1 − αL) ≥ 0,
Bδ − (1 − ǫ)βx20 ≥ 0,
A(a + dL − ρ) − Ba ≥ 0.
Thus, if R0 ≤ 1, we have V˙ |(1.1) ≤ 0. Since x, L, y, z are positive, we get V˙ = 0 if and only if
(x, L, y, z) = (x0, 0, 0). It thus follows from the classical Krasovskii-LaSalle principle [34, 35]
that E0 is globally asymptotically stable. 
The global asymptotic stability of the uninfected equilibrium E0 of system (1.1) biologi-
cally implies that the virus will die out in the host. Generally, with treatment strong enough,
we have R0 < 1 which guarantees the elimination of the virus.
10
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3.2. Stability analysis of Equilibrium E1
Theorem 3.3. Assume R0 > 1, if h < h1, h1 < h < h2 or h2 < h < h
∗∗, then the immune
free equilibrium E1 of system (1.1) is locally asymptotically stable. If h > h
∗∗, E1 is unstable.
Proof. The characteristic equation of the linearized system of (1.1) at E1 is given by
(λ3 + b1λ
2
+ b2λ + b3)
[
c(1 + h)y1
(1 + ηy1)(k + ry1)
− b
]
= 0,
where
b1 = d + (1 − ǫ)βy1 + a + dL − ρ︸      ︷︷      ︸
1©
+
aαL(1 − ǫ)βx1
a + dL − ρ︸            ︷︷            ︸
2©
b2 = d(a + dL − ρ + aL1y1 ) + (1 − ǫ)βaL1 + (1 − ǫ)βy1(a + dL − ρ)︸                      ︷︷                      ︸
3©
+ (1 − ǫ)βx1(1 − αL)(1 − ǫ)βy1︸                               ︷︷                               ︸
4©
b3 = aαL(1 − ǫ)βx1(1 − ǫ)βy1 + (a + dL − ρ)(1 − ǫ)βx1(1 − aL)(1 − ǫ)βy1.
It is easy to see that
1© × 4© + 2© × 3© − b3 = 0.
Thus, b1b2 − b3 > 0 holds true. Now, we discuss the sign of the eigenvalue
λ4 =
c(1 + h)y1
(1 + ηy1)(k + ry1)
− b
=
−brηy21 + (c + ch − br − bkη)y1 − bk
(1 + ηy1)(k + ry1)
,
which is determined by
∆ = (c + ch − br − bkη)2 − 4b2krη.
(i) If ∆ = 0, then h = h1 or h = h2, which is a critical situation.
(ii) If ∆ < 0, then h1 < h < h2, we have λ4 < 0.
(iii) If ∆ > 0, we have h < h1 or h > h2. To get λ4 < 0, we need to ensure that h <
br+bηk
c
− 1, R0 < 1 + R1 or R0 > 1 + R2, from which we can obtain that h < h∗∗. Here R1,2 =
β(1−ǫ)
[
B∓
√
B2−4b2ηrk
]
2bdrη
. Notice h2 < h
∗∗. It thus follows that if h < br+bηk
c
−1 or h2 < h < h∗∗, then
the eigenvalue λ4 < 0. If h > h
∗∗, we have λ4 > 0.
In summary, if h < h2 or h2 < h < h
∗∗, then λ4 < 0. From the Routh-Hurwitz criterion
[36, 37], with the assumption R0 > 1, if h < h2 or h2 < h < h
∗∗, the equilibrium E1 of system
(1.1) is locally asymptotically stable. On the other hand, when h > h∗∗, E1 is unstable. 
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Remark 3.1. (i) h1, h2 and h
∗∗ are critical values.
(ii) If R0 > 1 and h > h
∗∗, then the equilibrium E1 of system (1.1) is unstable.
Here, the elite control threshold h∗∗ determines whether a system is under elite control
[3]. Biologically, if the proliferation rate of CTLs is greater than the critical value h∗∗, the
virus may remain at high levels with no control.
3.3. Stability analysis of positive equilibria
We denote by E∗ = (x∗, L∗, y∗, z∗) an arbitrary positive equilibrium of system (1.1).
Theorem 3.4. (i) Assume (A) A3(A1A2 − A3) − A21A4 > 0. If
(A.1) 1 < R0 < Rc and h > h
∗∗, or
(A.2) R0 > Rc and h > h2,
system (1.1) has an immune equilibrium E∗
+
, which is a stable node.
(ii) If R0 > Rc and h2 < h < h
∗, system (1.1) also has an immune equilibrium E∗−, which
is an unstable saddle point.
Proof. The characteristic equation of the linearized system of (1.1) at the arbitrary positive
equilibrium E∗ is obtained as
λ4 + A1λ
3
+ A2λ
2
+ A3λ + A4 = 0,
where
A1 = a + dL − ρ + d + β(1 − ǫ)y∗ + aL∗y∗ ,
A2 = (a + dL − ρ)
[
d + β(1 − ǫ)y∗
]
+
aL∗
y∗
[
d + β(1 − ǫ)y∗
]
+py∗z∗ c(1+h)z
∗(k−ηry∗2)
(1+ηy∗)2(k+ry∗)2 + (1 − αL)(1 − ǫ)βx∗(1 − ǫ)βy∗,
A3 =
aL∗
y∗ (a + dL − ρ)(1 − ǫ)βy∗ + py∗z∗
c(1+h)z∗(k−ηry∗2)
(1+ηy∗)2(k+ry∗)2
[
a + dL − ρ + d + β(1 − ǫ)y∗
]
+(1 − αL)(1 − ǫ)βx∗(1 − ǫ)βy∗(a + dL − ρ),
A4 = py
∗z∗ c(1+h)z
∗(k−ηry∗2)
(1+ηy∗)2(k+ry∗)2 (a + dL − ρ)
[
d + β(1 − ǫ)y∗
]
.
Then we have
A1A2 − A3 = aL∗y∗ d(a + dL − ρ) + (aL
∗
y∗ )
2
[
d + β(1 − ǫ)y∗
]
+
aL∗
y∗ py
∗z∗ c(1+h)z
∗(k−ηry∗2)
(1+ηy∗)2(k+ry∗)2 +
aL∗
y∗ (1 − αL)(1 − ǫ)βx∗(1 − ǫ)βy∗
+
[
a + dL − ρ + d + β(1 − ǫ)y∗
]
(a + dL − ρ)
[
d + β(1 − ǫ)y∗
]
+
aL∗
y∗
[
d + β(1 − ǫ)y∗
][
a + dL − ρ + d + β(1 − ǫ)y∗
]
+(1 − αL)(1 − ǫ)βx∗(1 − ǫ)βy∗
[
a + dL − ρ + d + β(1 − ǫ)y∗
]
.
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(i) For equilibrium E∗
+
, we have
k − ηry∗2− < 0⇔ h > h2.
If h > h2, then A4 < 0. Clearly, Ai > 0, i = 1, 2, 3 and A1A2 − A3 > 0. If A3(A1A2 − A3) −
A2
1
A4 > 0, from the Routh-Hurwitz criterion [36, 37], we know that the positive equilibrium
E∗
+
is a stable node.
(ii) For equilibrium E∗−, we have
k − ηry∗2
+
> 0 ⇔ B − 2b
√
rkη <
√
B2 − 4b2rkη. (3.4)
For any positive h, (3.4) holds true. Thus, equilibrium E∗− is unstable. 
By Theorems 3.3 and 3.4, we have the following result.
Theorem 3.5. If R0 > Rc and h = h2, the immune equilibrium E
∗
− and E
∗
+
coincide with
each other and a saddle-node bifurcation occurs when h passes through h2. 
The stabilities of the equilibria and the behaviors of system (1.1) are summarized in
Tables 3 and 4.
Table 3.3: The stabilities of the equilibria and the behaviors of system (1.1). Here, h∗∗ is a critical value and
we assume A3(A1A2 − A3) − A21A4 > 0.
E0 E1 E
∗
+
E∗− System (1.1)
R0 < 1 GAS — — — Tends to E0
1 < R0 < Rc, 0 < h < h
∗∗ US LAS — — Tends to E1
1 < R0 < Rc, h
∗∗ < h US US LAS — Tends to E∗
+
4. Sensitive analysis and numerical simulations
4.1. Sensitive analysis
Sensitive analysis has been widely performed to investigate the basic reproductive num-
ber R0 in epidemic models [38]. In the following, we carry out sensitive analysis with the
aim of revealing the relationship between the basic infection reproductive number R0 and the
basic immune reproductive number R∗−, and system parameters in our model. Here, we use
latin hypercube sampling (LHS) and partial rank correlation coefficients (PRCCs) [39, 40]
to test the dependence of the basic infection reproduction number R0 and the basic immune
13
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Table 3.4: The stabilities of the equilibria and the behaviors of system (1.1). Here, h2, h
∗ and h∗∗ are critical
values, h2 is a saddle-node bifurcation point and we assume A3(A1A2 − A3) − A21A4 > 0.
E0 E1 E
∗
+
E∗− System (1.1)
R0 < 1 GAS — — — Tends to E0
R0 > 1, 0 < h < h2, US LAS — — Tends to E1
R0 > Rc, h2 < h < h
∗∗ US LAS LAS US Bistable
R0 > Rc, h
∗∗ < h < h∗ US US LAS US Tends to E∗
+
R0 > Rc, h > h
∗ US US LAS — Tends to E∗
+
reproduction number R∗−. As a statistical sampling method, LHS provides an efficient anal-
ysis of parameter variations across simultaneous uncertainty ranges in each parameter [39].
PRCC, on the other hand, shows the level of significance for each parameter. The PRCC
is obtained using the rank transformed LHS matrix and output matrix [40]. We performed
4000 simulations per run and used a uniform distribution function to test for the significance
of PRCCs for all parameters with wide ranges.
PRCC results Figs. 1 and 2 illustrate the dependence of R0 and R
∗
− on each system param-
eter respectively, and estimate the normal distributions for R0 and R
∗
−. When |PRCC| > 0.4,
there is significant correlation between input parameters and output variables. For |PRCC| ∈
(0.2, 0.4], the correlations are moderate. When |PRCC| ∈ [0, 0.2], we have weak correla-
tions. We notice that the proliferation rate of CD4+ T cells s, the decay rate of CD4+ T cells
d, the infection rate of CD4+ T cells β, the drug efficacy ǫ and the latently infected cell death
rate dL have significant influences on the infection reproduction number R0 and the immune
reproduction number R∗−.
4.2. Numerical simulations
In the following, we perform some numerical simulations to verify our analysis results.
The default parameter values are listed in Table 5.5.
Using these default parameters, we obtain the values of thresholds R0 ≈ 3.0030, Rc ≈
1.4243, h2 ≈ 0.7325, h∗ ≈ 1.4353 and h∗∗ ≈ 0.9174. The bistable interval is (0.7325, 0.9174).
Fig.3 indicates that there is no positive equilibrium for h < 0.7325, and a saddle-node bifur-
cation appears when h passes through 0.7325.
We are also interested in the influences of system parameters on the virus rebound thresh-
old h2 and the elite control threshold h
∗∗. From PRCCs. Fig.5, we can see that the decay rate
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of CTLs b, the effector cell production Hill function scaling η, the natural oxidant content k
significantly positively correlated to the virus rebound threshold h2. The proliferation rate of
CTLs c significantly negatively correlated to the virus rebound threshold h2.
Fig.6 indicates that the activation rate of viral latent reservoir a is significantly positively
correlated to the elite control threshold h∗∗. The proliferation rate of latently infected cells ρ
is significantly negatively correlated to the elite control threshold h∗∗.
Biologically, the increased decay rate of CTLs, the effector cell production Hill func-
tion scaling and the natural oxidant content make it difficult to treat the disease. While the
increased proliferation rate of CTLs are beneficial to the disease treatment.
5. Discussion
The bistability phenomenon can also appear in other HIV infection model with oxidative
stress. For example, we investigate the HIV infection model (5.2) with logistic proliferation
rate of latently infected cells, which can reveal the effects of proliferation rate of latently
infected cells on HIV infection model. Instead of using similar method as analyzing system
(1.1), we carry out simulations to show the existence of bistability. Fig. 7 shows that system
(5.2) has bistable behaviors for different initial values when Lmax = 50 ( the values of other
parameters are listed in Table 2).

dx(t)
dt
= s − dx(t) − (1 − ǫ)βx(t)y(t),
dL(t)
dt
= αL(1 − ǫ)βx(t)y(t) − (a + dL)L(t) + ρL(t)(1 −
L(t)
Lmax
),
dy(t)
dt
= (1 − αL)(1 − ǫ)βx(t)y(t) + aL(t) − δy(t) − py(t)z(t),
dz(t)
dt
=
cy(t)z(t)
1 + ηy(t)
1 + h
k + ry(t)
− bz(t).
(5.2)
In fact, the function
cy
1+ηy
1+h
k+ry
is a Monod-Haldane function [42] about y. We show the
predator-prey system with Monod-Haldane function or simplified Monod-Haldane function
also has bistability appear [43]. In viral infection systems, the models with nonmonotonic
immune responses has bistability appear. However, the model with monotonic immune re-
sponses has no bistability appear [44]. The bistability phenomenon also be discovered in a
NK-tumor-immune system [45].
In this paper, we design a simplified within host model to investigate the post-treatment
immune control and elite control of a disease. We obtain the model’s post-treatment immune
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control threshold and the elite control threshold, and show that the model displays rich dy-
namical behaviors. By performing sensitive analysis and numerical simulations, we find that
decreasing the immune impairment rate is beneficial for the host to obtain post-treatment
immune control and the elite control. A therapeutic strategy that decreases the immune im-
pairment rate of virus, decay rate of CTLs and effector cell production Hill function scaling is
helpful for the host to obtain elite control efficiently. The results have potential applications
in designing optimal treatment plan for corresponding diseases.
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Table 5.5: Parameters for model (1.1).
Symbol Description Value Reference
s Proliferation rate of CD4+ T cells 10 cells /µ L/ day [41]
d Decay rate of CD4+ T cells 0.01 day−1 [41]
β Infection rate of CD4+ T cells 0.015 µ L / day –
ǫ Drug efficacy 0.8 –
αL Fraction of newly infected cells that become latently infected 0.001 –
ρ Proliferation rate of latently infected cells 0.0045 day−1 [3]
a Activation rate 0.001 day−1 [3]
dL Latently infected cell death rate 0.004 day
−1 [3]
δ Infected cell death rate 1 day−1 [3]
p Killing rate of infected CD4+ T cells 0.1 day−1 –
c Proliferation rate of CTLs 0.1 day−1 –
η Effector cell production Hill function scaling 1 cells/µ L –
b Decay rate of CTLs 0.1 day−1 –
h Antioxidant paremater 0.8 day−1 –
k The natural oxidant content 1 cells /µ L –
r Oxidant content produced by HIV viral load 0.1 cells/µ L –
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Figure 1: Partial rank correlation coefficients illustrating the dependence of R0 for the model (1.1) on each
parameter and the frequency distribution of R0.
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Figure 2: Partial rank correlation coefficients illustrating the dependence of R∗− for the model (1.1) on each
parameter.
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Unstable Equilibrium E0
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Figure 3: Bistability and saddle-node bifurcation diagram of system (1.1). The bistable interval is
(0.7325, 0.9174). When h < 0.7325, the model has a high viral load steady state, which corresponds to vi-
ral rebound. When h > 0.9174, the model shows a low viral load steady state, which means that patients are
under elite control. When h is between the two values, the model shows bistability depending on the initial
conditions (population size of infected cells or immune cells at the time of treatment cessation). The parameter
values are shown in Table 5.
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Figure 4: The bistability of system (1.1). The initial values are x(0) = 600, L(0) = 80, y(0) = 20, z(0) = 1
(blue) and x(0) = 600, L(0) = 80, y(0) = 20, z(0) = 20 (red). The parameter values are listed in Table 5.
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Figure 5: Partial rank correlation coefficients illustrating the dependence of h2 on each parameter.
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Figure 6: Partial rank correlation coefficients illustrating the dependence of h∗∗ on each parameter.
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Figure 7: The bistability of system (1.1). Here, Lmax = 50. The initial values are x(0) = 600, L(0) = 20,
y(0) = 20, z(0) = 1 (blue) and x(0) = 600, L(0) = 80, y(0) = 20, z(0) = 20 (red). The parameter values are
listed in Table 5.
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